手机版 English 帮助中心
外文文献知网节
文献信息节点
基本信息 摘要 关键词 核心评价 相关文献
Journal | [J] 国际护理医学 Volume 4, Issue 4. 2022.
基于化学治疗耐药机制探究的乳腺癌科学研究进展与 卫生经济学研究并以赤峰市肿瘤医院为例进行讨论
作者 : 秦 　祎, 廖 艺涵, 王 梓晗, 刘 振雨
DOI: 10.12361/2661-4812-04-04-95247
全部来源
获取全文
摘要 / Abstract
乳腺癌是发生于乳腺癌周围的癌症，乳腺癌根治术后化疗是乳腺癌的常规临床医学治疗，化学治疗的机制 在分子细胞学上以抑制肿瘤细胞的有丝分裂为主。但是化学治疗后也常常伴有抗化疗药物的耐药机制的发生，并且 部分恶性患者生存率较低。我们尝试分析了部分化疗药物的作用机制通过科学实验对耐药机制进行探索，并进行分 析。通过药物价格与卫生经济学原则进行回报率等的讨论。
关键词 / Keywords
癌症；乳腺癌；化学治疗；耐药机制；有丝分裂；卫生经济学
Related articles / 相关文献
相似文献
作者发文
机构发文
关键词分析
相似文献（说明：与本文内容较接近的文献）
  • [1]Hassan, M. S. U., et al. “Chemotherapy for breast
  • cancer.” Oncology reports 24.5 (2010): 1121-1131.
  • [2]Anampa, J., Makower, D., & Sparano, J. A. (2015).
  • Progress in adjuvant chemotherapy for breast cancer: an
  • overview. BMC medicine, 13(1), 1-13.
  • [3]Fisher, B., Redmond, C., Brown, A., Wolmark, N.,
  • Wittliff, J., Fisher, E. R., ... & Shibata, H. (1981). Treatment of
  • primary breast cancer with chemotherapy and tamoxifen. New
  • England Journal of Medicine, 305(1), 1-6.
  • [4]O'Shaughnessy, Joyce. “Extending survival with
  • chemotherapy in metastatic breast cancer.” The oncologist
  • 10.S3 (2005): 20-29.
  • [5]Feldman, L. D., Hortobagyi, G. N., Buzdar, A. U.,
  • Ames, F. C., & Blumenschein, G. R. (1986). Pathological
  • assessment of response to induction chemotherapy in breast
  • cancer. Cancer Research, 46(5), 2578-2581.
  • [6]Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne,
  • C. K., Wu, M. F., ... & Chang, J. C. (2008). Intrinsic resistance
  • of tumorigenic breast cancer cells to chemotherapy. Journal of
  • the National Cancer Institute, 100(9), 672-679.
  • [7]Fisher, Bryant, et al. “Effect of preoperative
  • chemotherapy on the outcome of women with operable breast
  • cancer.” Journal of clinical oncology 16.8 (1998): 2672-2685.
  • [8]Schwartz, Anna L., et al. “Exercise reduces daily
  • fatigue in women with breast cancer receiving chemotherapy.”
  • Medicine & Science in Sports & Exercise 33.5 (2001): 718-
  • 723.
  • [9]Rouzier, R., Perou, C. M., Symmans, W. F., Ibrahim, N.,
  • Cristofanilli, M., Anderson, K., ... & Pusztai, L. (2005). Breast
  • cancer molecular subtypes respond differently to preoperative
  • chemotherapy. Clinical cancer research, 11(16), 5678-5685.
  • [10]Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M.,
  • Houssami, N., Poortmans, P., ... & Cardoso, F. (2019). Breast
  • cancer. Nature reviews Disease primers, 5(1), 1-31.
  • [11]Arribas, J., Baselga, J., Pedersen, K., & Parra-Palau,
  • J. L. (2011). p95HER2 and breast cancer. Cancer research,
  • 71(5), 1515-1519.
  • [12]Key T J, Verkasalo P K, Banks E. Epidemiology of
  • breast cancer[J]. The lancet oncology, 2001, 2(3): 133-140.
  • [13]Elmore, J. G., Armstrong, K., Lehman, C. D., &
  • Fletcher, S. W. (2005). Screening for breast cancer. Jama,
  • 293(10), 1245-1256.
  • [14]Scully, Olivia Jane, et al. “Breast cancer metastasis.”
  • Cancer genomics & proteomics 9.5 (2012): 311-320.
《中国学术期刊(光盘版)》电子杂志社有限公司 KDN平台基础技术由KBASE 11.0提供
© 2014-2018中国知网(CNKI) 京公网安备11010802020460号 经营性网站备案信息 互联网出版许可证 新出网证(京)字271号 京ICP证040431号